Molecular Partners AG (MOLN)
3.87
+0.16
(+4.31%)
USD |
NASDAQ |
May 16, 16:00
Molecular Partners Stock Buybacks (Quarterly): 0.00 for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | 0.0114M |
September 30, 2022 | 0.6502M |
Date | Value |
---|---|
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | -0.2498M |
September 30, 2021 | 1.524M |
June 30, 2021 | -57.61M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-57.61M
Minimum
Jun 2021
1.524M
Maximum
Sep 2021
-7.954M
Average
--
Median
Sep 2023
Stock Buybacks (Quarterly) Benchmarks
AC Immune SA | -0.0023M |
CRISPR Therapeutics AG | -280.74M |
Addex Therapeutics Ltd | -1.304M |
NLS Pharmaceutics Ltd | -- |
MoonLake Immunotherapeutics | -52.54M |